Unknown

Dataset Information

0

Integrated pan-cancer analysis of RNA binding protein HuR investigates its biomarker potential in prognosis, immunotherapy, and drug sensitivity

ABSTRACT:

SUBMITTER: Peng J 

PROVIDER: S-EPMC12377624 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
| S-EPMC8134747 | biostudies-literature
Unknown CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.
| S-EPMC11413897 | biostudies-literature
Unknown Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
| S-EPMC9657346 | biostudies-literature
Unknown Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy.
| S-EPMC6827986 | biostudies-literature
Unknown Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma.
| S-EPMC11579764 | biostudies-literature
Unknown An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy.
| S-EPMC9465327 | biostudies-literature
Unknown Comprehensive pan-cancer analysis of ACSS3 as a biomarker for prognosis and immunotherapy response.
| S-EPMC11334676 | biostudies-literature
Unknown Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis.
| S-EPMC9425067 | biostudies-literature
Unknown Pro-apoptotic gene BAX is a pan-cancer predictive biomarker for prognosis and immunotherapy efficacy.
| S-EPMC11315380 | biostudies-literature
Unknown Pan-cancer analysis identifies the IRF family as a biomarker for survival prognosis and immunotherapy.
| S-EPMC10844690 | biostudies-literature